VCU Clinical Research Quality Assurance Assessment

Similar documents
Regulatory Binder Checklist for FDA-Regulated Sponsor/Sponsor-Investigator Studies

Self-Monitoring Tool

BIMO SITE AUDIT CHECKLIST

Initially Submitted on 11/24/2009 Final Submission By Test6 CA on 11/24/2009 1:51 PM Approval By student13 student13 on 11/24/2009 1:52 PM Attendees

WIRBinar. How to Survive an FDA Inspection. Upcoming Trainings: Contact Us: (360)

The GCP Perspective on Study Monitoring

HIC Standard Operating Procedure. For-Cause Audits of Human Research Studies

Good Clinical Practice: A Ground Level View

QUALITY ASSURANCE PROGRAM

Good Documentation Practices. Human Subject Research. for

Mastering Clinical Research April 19, :30 am

CLOSE OUT VISIT REPORT (NO CRF TO MONITOR)

Clinical Trial Quality Assurance Common Findings

SARASOTA MEMORIAL HOSPITAL CANCER RESEARCH PROGRAM POLICY

General Administration GA STANDARD OPERATING PROCEDURE FOR Sponsor Responsibility and Delegation of Responsibility

Standard Operating Procedures

Dr. R. Sathianathan. Role & Responsibilities of Principal Investigators in Clinical Trials. 18 August 2015

Building Quality into Clinical Trials. Amy C. Hoeper, MSN, RN, CCRC, Quality Manager Cincinnati Children s Gamble Program for Clinical Studies

STUDY INFORMATION POST-IRB APPROVAL FDA DEVICE (IDE) SPONSOR AND INVESTIGATOR RESPONSIBILITY (21 CFR 812)

Site Qualification and Training (SQT) INFORMATION AND GUIDANCE SHEET FOR SITE SIGNATURE AND DELEGATION OF RESPONSIBILITIES LOG

Documenting the Story of a Clinical Trial: Concept to CAPA. Lori T. Gilmartin Gilmartin Consulting LLC

Local VA VA ORD CSP Other VA ORD. IRB of Record Registration Number: IRB Operated by: Local VA Non-local VA Academic Affiliate VHA Central IRB

TITLE: Reporting Adverse Events SOP #: RCO-204 Page: 1 of 5 Effective Date: 01/31/18

Research Audits PGR. Effective: 12/04/2013 Reviewed: 12/04/2015. Name of Associated Policy: Palmetto Health Administrative Research Review

FDA Inspection Readiness

Checklist prior to recruiting first patient

Unofficial copy not valid

Trial Management: Trial Master Files and Investigator Site Files

Standard Operating Procedure (SOP) Research and Development Office

managing or activities.

Site Closedown Checklist for UoL Sponsored CTIMP Studies

NN SS 401 NEURONEXT NETWORK STANDARD OPERATING PROCEDURE FOR SITE SELECTION AND QUALIFICATION

PLATELET-ORIENTED INHIBITION ISCHEMIC STROKE (POINT) MONITORING PLAN IN NEW TIA AND MINOR. Version 2.0 Updated 11 May 2017

The Clinical Research Center Research Practice Manual. Guideline for Study Document and Data Handling RPG-08. Guideline. Purpose.

Study Monitoring Plan Template

EMA Inspection Site perspective

Monitoring Clinical Trials

STANDARD OPERATING PROCEDURE SOP 710. Good Clinical Practice AUDIT AND INSPECTION. NNUH UEA Joint Research Office. Acting Research Services Manager

11/18/2016. UC Irvine s Clinical Research Coordinator Certification Preparation Series PI Roles and Responsibilities SESSION 4

Study Start-Up SS STANDARD OPERATING PROCEDURE FOR PRE-STUDY SITE VISIT (PSSV)

GCP: Investigator Responsibilities. Susan Tebbs Nicola Kaganson

SOP MONITORING & OVERSIGHT OF RESEARCH ACTIVITY. Contact Jess Bisset, Research Operations Manager x20227

Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust

GCP INSPECTION CHECKLIST

Study Management SM STANDARD OPERATING PROCEDURE FOR Adverse Event Reporting

STUDY TEAM RESPONSIBILITIES ORIENTATION FOR NEW CLINICAL RESEARCH PERSONNEL MODULE 2

Record or Document Type Retention Period Relevant Legal Citation(s) IRB Records: Training Records;

ACTIONS/PSOP/001 Version 1.0 Page 2 of 6

SOP-QA-28 V2. Approver: Prof Maggie Cruickshank, R&D Director Approver: Prof Steve Heys, Head of School

Standard Operating Procedure. Essential Documents: Setting Up a Trial Master File. SOP effective: 19 February 2016 Review date: 19 February 2018

QUALITY TIPS FOR CLINICAL SITES. Athena Thomas-Visel. Clinical Quality Consultant QUALITY TIPS FOR CLINICAL SITES

Standard Operating Procedure INVESTIGATOR OVERSIGHT OF RESEARCH. Chief and Principal Investigators of research sponsored and/or hosted by UHBristol

MARKEY CANCER CENTER CLINICAL RESEARCH ORGANIZATION STANDARD OPERATING PROCEDURES SOP No.: MCCCRO-D

Trial set-up, conduct and Trial Master File for HEY-sponsored CTIMPs

Document Title: Study Data SOP (CRFs and Source Data)

Roles & Responsibilities of Investigator & IRB

Investigator Site File Standard Operating Procedure (SOP)

MHRA Findings Dissemination Joint Office Launch Jan Presented by: Carolyn Maloney UHL R&D Manager

Investigator-Initiated Studies: When you re the Sponsor. Cheri Robert & Tammy Mah-Fraser

Standard Operating Procedure (SOP) for Reporting Serious Breaches in Clinical Research

FDA Medical Device Regulations vs. ISO 14155

LOUIS STOKES CLEVELAND VA MEDICAL CENTER RESEARCH SERVICE Human Subject Protection Standard Operating Procedure (SOP)

IN ACCORDANCE WITH THIS INTERNATIONAL DEVICE STANDARD

Office of the Vice Chancellor for Research Supervisory Responsibilities of Clinical Investigators

Study Management PP STANDARD OPERATING PROCEDURE FOR Safeguarding Protected Health Information

Successful FDA Inspections at Investigative Sites for Clinical Trials of Drugs and Biologics

Document Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026

Tufts Medical Center (Tufts MC) and Tufts University Health Sciences (TUHS) IRB Western IRB (WIRB) Submission Policy

Presented by NC TraCS Institute UNC Office of Clinical Trials UNC Network of Clinical Research Professionals

Public Input for Changes to Reportable Events Policy

Standard Operating Procedure

RITAZAREM CRF Completion Guidelines

Comprehensive Protocol Feasibility Questionnaire

How to Prepare for Federal Inspections and What to Expect

Theradex Audit 2013: Findings & Corrective Action

Essential Documents It s Not Just a Binder!

SOP: New Revised Reviewed Effective Date: 08 October Approved by : Supervisor/Manager Risk/Ethics Sr. Mgmt Committees Board/Councils

Vertex Investigator-Initiated Studies Program Overview

Standard Operating Procedure (SOP)

Roles of Investigators in the Managements of Clinical Trials

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

36 th Annual Meeting Preconference Workshop P4 Handout

Audits/Inspections Be Prepared for Anything

August 3, 2017 Clinical Trials at UNC. UNC Symposium for Research Administrators

AN OVERVIEW OF CLINICAL STUDY TASKS AND ACTIVITIES

Sponsor Responsibilities. Roles and Responsibilities. EU Directives. UK Law

MANAGEMENT OF PROTOCOL AND GCP DEVIATIONS AND VIOLATIONS

Subject Research Records. Essential Regulatory and Source Documents. Subject Research Records. Regulatory Files

Request to Use an External IRB as an IRB of Record

Signature Date Date First Effective: Signature Date Revision Date:

Joint R&D Support Office SOP S-2011 UHL

SAINT AGNES MEDICAL CENTER CLINICAL RESEARCH CENTER Fresno, California. STANDARD OPERATING PROCEDURES Institutional Review Board

STANDARD OPERATING PROCEDURE

Document Number: 006. Version: 1. Date ratified: Name of originator/author: Heidi Saunders, Senior Portfolio Coordinator

DANA-FARBER / HARVARD CANCER CENTER POLICIES FOR HUMAN SUBJECT RESEARCH TITLE:

Guideline for the notification of serious breaches of Regulation (EU) No 536/2014 or the clinical trial protocol

20 STEPS FROM STUDY IDEA INCEPTION TO PUBLISHING RESEARCH/ Evidence-Based Practice

Standard Operating Procedures

PROMPTLY REPORTABLE EVENTS

General Administration GA STANDARD OPERATING PROCEDURE FOR Document Development and Change Control

Transcription:

VCU Clinical Research Quality Assurance Assessment Principal Investigator Protocol Title Protocol IRB Number Name of Person Completing Assessment Date Assessment was Completed The goal of this assessment is to assure that the rights and well-being of human subjects are protected, the reported study data are accurate, complete, and verifiable, and the study is being conducted according to Federal Regulations, Policies, Guidance, VCU policies and conditions of IRB approval. Please upload this form at the time of your continuing review submission as a document at go.vcu.edu/submit/monitor. Amendments and reports should be submitted through RAMS-IRB. Document Revision History: Version1: April 13, 2017 Version2: May 9, 2017 Version3: August 28, 2017 Version4: October 3, 2017 Version5: October 10, 2017 1 VCU Clinical Research Quality Assurance Assessment v5

Monitoring by Other Groups In the last year, has your study been monitored by a Clinical Research Organization (CRO), Massey Cancer Center, VCU Johnson Center, or other internal/external monitoring group? If No, please go to the next page and complete the Quality Assurance Assessment for your study If Yes, please complete the next two questions and proceed to the Overall Assessment section on the last page. 1. What group monitored? 2. When was your last monitoring visit? Signature of study staff member completing this form Date Signature of Investigator reviewing this form Date. 2 VCU Clinical Research Quality Assurance Assessment v5

Consent Process Worksheet If your study obtains signed consent/parental permission/assent, complete this section by randomly selecting 10 enrolled subjects. After reviewing their consent/parental permission/assent documents (referred to as the ICF below), then answer the following questions. If less than 10 subjects have enrolled since the last assessment, review all subjects. Participant ID Number: 1 2 3 4 5 Notes and/or Explanation of any No Answers: Was the most recently approved version of the consent document utilized? Is the IRB s approval stamp present and legible on the ICF? Is there an original copy of the ICF on file? Are all pages of the ICF present? Are all options in the ICF completed? Are all required signatures present? Is the person who obtained consent on the personnel list and delegated to this task? Was the ICF signed prior to any study related procedures being performed? Was a copy of the ICF given to the participant? Was the consent process documented in the case records including the Medical Record (as appropriate)? Was the assent process conducted as approved? For short form consents, were the required individuals present and required signatures obtained? Is there an original copy of the HIPAA authorization on file? Are all required signatures present on the HIPAA authorization? 3 VCU Clinical Research Quality Assurance Assessment v5

Consent Process Worksheet continued Participant ID Number: 6 7 8 9 10 Notes and/or Explanation of any No Answers: Was the most recently approved consent document utilized? Is the IRB s approval stamp present and legible on the ICF? Is there an original copy of the ICF on file? Are all pages of the ICF present? Are all options in the ICF completed? Are all required signatures present? Is the person who obtained consent on the personnel list and delegated to this task? Was the ICF signed prior to any study related procedures being performed? Was a copy of the ICF given to the participant? Was the assent process conducted as approved? For short form consents, were the required individuals present and required signatures obtained? Is there an original copy of the HIPAA authorization on file if separate from the ICF? Are all required signatures present on the HIPAA authorization if separate from the ICF? 4 VCU Clinical Research Quality Assurance Assessment v5

Study Documentation Worksheet Personnel Are all engaged personnel approved by the IRB? (i.e. Are they listed as personnel in RAMS-IRB?) Are the delegation and signature log(s) up to date and include all personnel? Have all personnel completed required CITI training (HSR & GCP as applicable)? Have all personnel completed protocol specific training and is documentation present (i.e. training logs)? Are the credentials of all personnel current and documented (i.e. CV, license)? Safety Reporting Have all deviations from the protocol, SOPs, GCP, and/or any other regulatory requirements been communicated as necessary? Were all adverse events (AEs) documented and reported appropriately within the required time periods? Are your compiled AEs, SAEs, UPs, deviations on file or readily available in OnCore? Research Facilities Are all facilities (including laboratories and equipment) adequate to safely and properly conduct the study? Have all research sites been approved by the IRB? Drug/Device Accountability Is the Investigational Pharmacy Plan or Device Storage & Dispensing Plan being followed? Are your Drug/Device Accountability Records on file or readily available? 5 VCU Clinical Research Quality Assurance Assessment v5

IRB Approval Are all protocols, measures, ICFs, recruitment materials, and other items given to subjects the most recent, IRB approved versions? Were all protocol changes/ amendments only implemented after being approved by the IRB? Study Data Have all subjects been entered into OnCore? Have all screen failures data been destroyed per IRB protocol? Are data being stored securely per your approved protocol? ClinicalTrials.gov Is clinicaltrials.gov up to date for your study? Billing If there have been any changes to the protocol that require the Cost Coverage Analysis, has it been updated? Study Documentation Have you identified any issues with study documentation in your files? 6 VCU Clinical Research Quality Assurance Assessment v5

Subject Case History Review Select three (3) or more subject files to review. Review study procedures paying attention to deviations, missing data, and study windows. Review for AEs/SAEs, including the required documentation and reporting of these events. Review whether all forms are complete with signatures and/or initials where required. Subject 1: ID # Did the subject meet eligibility criteria and is it documented in the case files? Were the subject visits conducted within the protocol-designated time frame? Were all tests/procedures performed according to the protocol and in the protocoldesignated time frames? Was the correct treatment/intervention used and documented? Are all missed visits, visits not conducted, and examinations not performed clearly reported on the CRFs? Are any dose and/or therapy modifications well documented? Did the subject experience any AEs or SAEs? If yes, were these recorded and reported as required? Are all source documents? Accurate Complete Up to date Properly Maintained Are the CRF's consistent with the source documents? Are any AEs, concomitant medications, and intercurrent illnesses reported in accordance with the protocol on the CRFs? Are there any CRF entry errors, omissions, or eligibility concerns? If yes, are any corrections, additions, or deletions in the CRF dated, explained (if necessary), and initialed? 7 VCU Clinical Research Quality Assurance Assessment v5

Subject 2: ID # Did the subject meet eligibility criteria and is it documented in the case files? Were the subject visits conducted within the protocol-designated time frame? Were all tests/procedures performed according to the protocol and in the protocoldesignated time frames? Was the correct treatment/intervention used and documented? Are all missed visits, visits not conducted, and examinations not performed clearly reported on the CRFs? Are any dose and/or therapy modifications well documented? Did the subject experience any AEs or SAEs? If yes, were these recorded and reported as required? Are all source documents? Accurate Complete Up to date Properly Maintained Are the CRFs consistent with the source documents? Are any AEs, concomitant medications, and intercurrent illnesses reported in accordance with the protocol on the CRFs? Are there any CRF entry errors, omissions, or eligibility concerns? If yes, are any corrections, additions, or deletions in the CRF dated, explained (if necessary), and initialed? 8 VCU Clinical Research Quality Assurance Assessment v5

Subject 3: ID # Did the subject meet eligibility criteria and is it documented in the case files? Were the subject visits conducted within the protocol-designated time frame? Were all tests/procedures performed according to the protocol and in the protocoldesignated time frames? Was the correct treatment/intervention used and documented? Are all missed visits, visits not conducted, and examinations not performed clearly reported on the CRFs? Are any dose and/or therapy modifications well documented? Did the subject experience any AEs or SAEs? If yes, were these recorded and reported as required? Are all source documents? Accurate Complete Up to date Properly Maintained Are the CRFs consistent with the source documents? Are any AEs, concomitant medications, and intercurrent illnesses reported in accordance with the protocol on the CRFs? Are there any CRF entry errors, omissions, or eligibility concerns? If yes, are any corrections, additions, or deletions in the CRF dated, explained (if necessary), and initialed? 9 VCU Clinical Research Quality Assurance Assessment v5

Overall Assessment- go.vcu.edu/submit/monitor #1- Consent Have you identified any issues with consenting? If so, what? Do you need to do any of the following regarding your consenting process? #2- Personnel Have any personnel issues been identified? If so, what? Do you need to do any of the following regarding personnel? #3- Safety Reporting Have any safety reporting issues been identified? If so, what? Do you need to do any of the following regarding safety reporting? #4- Research Facilities Have any facility issues been identified? If so, what? Do you need to do any of the following regarding your research facilities? #5- Drug/Device Accountabilities Have you identified any issues with the investigational product dispensing or your storage plan? If so, what? Do you need to do any of the following regarding your investigational product storage or dispensing? 10 VCU Clinical Research Quality Assurance Assessment v5

#6- IRB Approval Have you identified any issues with the version of documents approved by the IRB? If so, what? Do you need to do any of the following regarding your IRB documents? #7- Study Data Have you identified any issues with study data? If so, what? Do you need to do any of the following regarding study data? o Other, define #8- ClinicalTrials.gov Have any issues with clinicaltrials.gov been identified? If so, what? Do you need to do any of the following regarding clinicaltrials.gov? o Submit changes o Other, define #9- Billing If there have been any changes to the protocol that require changes to the cost coverage analysis have these been submitted? If so, what? #10- Study Documentation Have any study documentation issues been identified? If so, what? Do you need to do any of the following regarding personnel? o Other, define #10- Subject Case History Review. 11 VCU Clinical Research Quality Assurance Assessment v5 After review of at least 3 participants did you note any issues which require any of the following (choose all that apply). o Re-education of staff o Reporting to the IRB or FDA o Protocol amendment o No action required

After reviewing your study, did you or will you do any of the following? Choose all that apply. Would you like an educational visit to discuss any issues, questions, or procedures? 1. Re-educate your Study Staff 2. Make an Amendment to your Protocol 3. Update your Study Documents 4. Submit a Report to the IRB 5. Develop a Corrective Action / Preventative Action (CAPA) Plan 6. Redesign your Case Report Forms (CRFs) 7. Develop Tools, Logs, and/or Templates 8. Seek Internal VCU Support or Education 9. Other, specify. If Yes, please provide name and contact information for who we should contact regarding an educational visit. Please provide any other comments or feedback. How helpful was this review in increasing the quality of your study? 12 VCU Clinical Research Quality Assurance Assessment v5